Get started
Author

Vanessa Infante

Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
2024 · Esper G. Kallás, Monica A.T. Cintra, et al. · New England Journal of Medicine · 215
Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil
2024 · Mauricio L Nogueira, Monica A T Cintra, et al. · The Lancet Infectious Diseases · 70
Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine
2026 · Esper G. Kallás, José A. Moreira, et al. · Nature Medicine · 27
PDF
Systematic review and meta-analysis of HPV vaccination in women with systemic lupus erythematosus (SLE)
2021 · Vanessa Infante, Karina Takesaki Miyaji, et al. · Expert Review of Vaccines · 21
A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers
2019 · Bruno A. Randi, Odeli Nicole Encinas Sejas, et al. · Vaccine · 20
Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant
2024 · Karina Takesaki Miyaji, Vanessa Infante, et al. · Frontiers in Cellular and Infection Microbiology · 11
PDF
Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil
2022 · Karina Takesaki Miyaji, Vanessa Infante, et al. · PLoS ONE · 11
PDF
Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in São Paulo, Brazil: need for continuous surveillance and implementation of active strategies
2019 · Bruno Azevedo Randi, Karina Takesaki Miyaji, et al. · The Brazilian Journal of Infectious Diseases · 11
PDF
Zika virus
2016 · Marta Heloisa Lopes, Karina Takesaki Miyaji, et al. · Revista da Associação Médica Brasileira · 8
PDF
Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan
2018 · Gabriella Mondini, Patricia Emilia Braga, et al. · Revista do Instituto de Medicina Tropical de São Paulo · 7
PDF
Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons
2024 · Karim Yaqub Ibrahim, Raquel Megale Moreira, et al. · Revista do Instituto de Medicina Tropical de São Paulo · 4
PDF
Randomized, double-blind, placebo-controlled, phase 3 trial to demonstrate lot-to-lot consistency of 3 lots of the simplified formulation of Butantan-dengue vaccine
2025 · Érique José Farias Peixoto de Miranda, José Alfredo de Sousa Moreira, et al. · Vaccine · 3
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil
2025 · Érique José Farias Peixoto de Miranda, Rodrigo T. Calado, et al. · Vaccine · 2
Blood-Borne Dengue Virus: A Case Report of Severe Dengue in a Hematopoietic Stem Cell Recipient
2016 · Maysa Alves, Vanessa Infante, et al. · Open Forum Infectious Diseases · 2
PDF
Human papillomavirus (HPV) seroprevalence, cervical HPV prevalence and cervical lesions in systemic lupus erythematosus (SLE) and immunocompetent women
2026 · Vanessa Infante, Karina Takesaki Miyaji, et al. · Lupus Science & Medicine · 1
PDF
Evaluating the safety profile of the CoronaVac in adult and older adult populations: A phase IV prospective observational study in Brazil
2025 · Monica Akissue de Camargo Teixeira Cintra, Eder Gatti Fernandes, et al. · PLOS Global Public Health · 1
PDF
Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals
2025 · Karina Takesaki Miyaji, Karim Yaqub Ibrahim, et al. · Revista do Instituto de Medicina Tropical de São Paulo · 1
Avaliação da resposta imune primária e segurança da vacina quadrivalente contra o papilomavírus humano (HPV) em mulheres com lúpus eritematoso sistêmico (LES)
2026 · Vanessa Infante
Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses
2024 · Lívia Zignago Moreira dos Santos, Camila Cristina Martini Rodrigues, et al. · Frontiers in Cellular and Infection Microbiology
PDF
Evaluating the Safety Profile of the CoronaVac in Adult and Elderly populations: A Phase IV Prospective Observational Study in Brazil
2023 · Monica Akissue de Camargo Teixeira Cintra, Eder Gatti Fernandes, et al. · medRxiv
PDF
Avaliação Da Resposta Imune Primária E Segurança Da Vacina De Hpv Quadrivalente Em Mulheres Transplantadas De Órgãos Sólidos
2022 · Karina Takesaki Miyaji, Vanessa Infante, et al. · The Brazilian Journal of Infectious Diseases
PDF
Uso das vacinas de HPV em imunocomprometidos (não HIV/aids): revisão sistemática da literatura e metanálise
2021 · Vanessa Infante
PDF
Use of HPV vaccines in immunocompromised persons (non-HIV/AIDS): a systematic review and meta-analysis
2021 · Infante, Vanessa · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Works count: 27
Citation count: 411
H-index: 8
I10-index: 7
Year
Topic
Type